Low blood glucose is linked to worsening eye disease in a new study. Medscape Medical News
Category: News
TRS 2025
Read clinically focused news coverage of key developments from TRS 2025 Medscape Ophthalmology
Atropine Drops Not Tied to Ocular Issues in Kids With Myopia
Children with myopia experience more eye problems than those without the condition, but atropine eye drops do not appear to increase that risk, a new study finds. Medscape Medical News
Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced that enrollment…
Tips for Being Efficient on Night Shift
Dr Kaitlin Sanzone discusses tips and tricks to be efficient on night shift. Medscape
Inflammasome Therapeutics’ K8 Implant Cuts Lesion Growth by more than 50% in Geographic Atrophy after Three Months in Multi-Center Trial
NEWTON, Mass.–(BUSINESS WIRE)– #NRTIs–Inflammasome Therapeutics (https://www.inflam.com), is a clinical-stage biotech company developing a new class of inflammasome inhibitors called Kamuvudines for ophthalmic and neurological conditions. Today, the…
Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the American Journal of Ophthalmology has published results o…
Poll: Are You Practicing Medicine Abroad? Would You Like To?
Medscape’s editors are investigating what is needed to practice medicine in various countries around the world, and we want to hear from you! Medscape Reader Polls
AMD Gene Therapy Sustains Efficacy in First Two-Eye Study
A gene therapy for neovascular age-related macular degeneration in the second eye shows safety and preservation of vision and anatomy a year after the first eye was treated. Medscape Medical News
Do You Really See What I See?
Do we all see the same color when we look at a banana? Dr F. Perry Wilson comments on a study that explores the human perception of color. Medscape
Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of ASANA gas permeable (GP) lenses. ASANA offers e…
Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025
GENEVA–(BUSINESS WIRE)–Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025
Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025
GENEVA–(BUSINESS WIRE)–Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025
Cancer Patients Request Financial Support Exceeding $5000
Researchers analyzed requests for assistance from patients with cancer enrolled in a novel digital support registry. Medscape Medical News
LambdaVision Secures NASA Phase 2 InSPA Award to Advance Manufacturing Efforts in Low-Earth Orbit
WOODBRIDGE, Conn.–(BUSINESS WIRE)–LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, has been awarded a National Aeronautics and Space Administ…
LambdaVision Secures NASA Phase 2 InSPA Award to Advance Manufacturing Efforts in Low-Earth Orbit
WOODBRIDGE, Conn.–(BUSINESS WIRE)–LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, has been awarded a National Aeronautics and Space Administ…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…